GlassScriptPhysician profile
Nathan J Abraham
NPI 1306224456
$8,405.86
in general payments reported to CMS, 2019-2025
16 companies · $861 in 2025
The $861 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $27.05 · 2021: $104 · 2022: $1,189 · 2023: $3,123 · 2024: $2,648 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,632.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $4,038.04 | 2022-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Alcon Vision LLC | $1,765.24 | 2019-2025 | Ngenuity, Hydrus Microstent, Rhopressa |
| Glaukos Corporation | $759.85 | 2019-2024 | Idose |
| Rxsight INC | $602.20 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Abbvie INC. | $186.90 | 2022-2024 | Ozurdex |
| Johnson & Johnson Surgical Vision, INC. | $182.89 | 2025 | Tecnis Simplicity |
| Nova Eye, INC. | $168.44 | 2023 | |
| Bausch & Lomb Americas INC. | $146.75 | 2023-2024 | Miebo, Xiidra, Envista Mx60 Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $140.97 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $133.67 | 2024 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $128.11 | 2023-2024 | Lumera 700, Clarus |
| Carl Zeiss Meditec, INC. | $69.56 | 2023 | |
| Dompe US, INC. | $33.41 | 2022 | |
| Sight Sciences, INC. | $20.04 | 2022 | |
| Lombart Brothers, INC. | $15.66 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.